NantHealth Announces Pricing of Initial Public Offering
On June 1, 2016, NantHealth, a next-generation personalized healthcare company, announced the pricing of its initial public offering of 6,500,000 shares of its common stock at a price to the public of $14.00 per share. The shares began trading on the Nasdaq Global Select Market on June 2 under the ticker symbol "NH." Wilson Sonsini Goodrich & Rosati is advising NantHealth in the offering.
NantHealth has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock. Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering; First Analysis Securities Corporation, Canaccord Genuity Inc., and FBR Capital Markets & Co. are acting as co-managers.
For more information, please see NantHealth's press release.